10
Array
(
    [0] => Array
        (
            [0] => Global Paroxetine Market Research Report 2017\n
            [title] => Global Paroxetine Market Research Report 2017\n
            [1] => 10440571
            [prod_id] => 10440571
            [2] => 18,20
            [cat_names] => 18,20
            [3] => 2017-01-26 00:00:00
            [prod_date] => 2017-01-26 00:00:00
            [4] => report
            [type] => report
            [5] => 1
            [status] => 1
            [6] => Mohit Parmar
            [author_id] => Mohit Parmar
        )

    [1] => Array
        (
            [0] => United States Paroxetine Market Report 2017
            [title] => United States Paroxetine Market Report 2017
            [1] => 10468173
            [prod_id] => 10468173
            [2] => 18,20
            [cat_names] => 18,20
            [3] => 2017-02-09 00:00:00
            [prod_date] => 2017-02-09 00:00:00
            [4] => report
            [type] => report
            [5] => 1
            [status] => 1
            [6] => Mohit Parmar
            [author_id] => Mohit Parmar
        )

    [2] => Array
        (
            [0] => Europe Paroxetine Market Report 2017
            [title] => Europe Paroxetine Market Report 2017
            [1] => 10494874
            [prod_id] => 10494874
            [2] => 18,20
            [cat_names] => 18,20
            [3] => 2017-02-21 00:00:00
            [prod_date] => 2017-02-21 00:00:00
            [4] => report
            [type] => report
            [5] => 1
            [status] => 1
            [6] => Mohit Parmar
            [author_id] => Mohit Parmar
        )

    [3] => Array
        (
            [0] => China Paroxetine Market Research Report 2017
            [title] => China Paroxetine Market Research Report 2017
            [1] => 10503645
            [prod_id] => 10503645
            [2] => 18,20
            [cat_names] => 18,20
            [3] => 2017-02-28 00:00:00
            [prod_date] => 2017-02-28 00:00:00
            [4] => report
            [type] => report
            [5] => 1
            [status] => 1
            [6] => Mohit Parmar
            [author_id] => Mohit Parmar
        )

    [4] => Array
        (
            [0] => Global Paroxetine Market Analysis & Forecast Report 2017-2022
            [title] => Global Paroxetine Market Analysis & Forecast Report 2017-2022
            [1] => 10548227
            [prod_id] => 10548227
            [2] => 18,20
            [cat_names] => 18,20
            [3] => 2017-02-17 00:00:00
            [prod_date] => 2017-02-17 00:00:00
            [4] => report
            [type] => report
            [5] => 1
            [status] => 1
            [6] => Mohit Parmar
            [author_id] => Mohit Parmar
        )

    [5] => Array
        (
            [0] => Global and Chinese Paroxetine HCl’ Hemihydrate (CAS 110429-35-1) Industry, 2016 Market Research Report
            [title] => Global and Chinese Paroxetine HCl’ Hemihydrate (CAS 110429-35-1) Industry, 2016 Market Research Report
            [1] => 10226308
            [prod_id] => 10226308
            [2] => 24
            [cat_names] => 24
            [3] => 2016-06-08 00:00:00
            [prod_date] => 2016-06-08 00:00:00
            [4] => report
            [type] => report
            [5] => 1
            [status] => 1
            [6] => Mohit Parmar
            [author_id] => Mohit Parmar
            [7] => 15.461596488952637
            [relevance] => 15.461596488952637
        )

    [6] => Array
        (
            [0] => Global and Chinese Paroxetine hcl Industry, 2016 Market Research Report
            [title] => Global and Chinese Paroxetine hcl Industry, 2016 Market Research Report
            [1] => 10273856
            [prod_id] => 10273856
            [2] => 18,20
            [cat_names] => 18,20
            [3] => 2016-07-28 00:00:00
            [prod_date] => 2016-07-28 00:00:00
            [4] => report
            [type] => report
            [5] => 1
            [status] => 1
            [6] => Mohit Parmar
            [author_id] => Mohit Parmar
            [7] => 15.461596488952637
            [relevance] => 15.461596488952637
        )

    [7] => Array
        (
            [0] => 2016 Paroxetine Hydrochloride (CAS 78246-49-8) Industry Market Report
            [title] => 2016 Paroxetine Hydrochloride (CAS 78246-49-8) Industry Market Report
            [1] => 10281236
            [prod_id] => 10281236
            [2] => 18,20
            [cat_names] => 18,20
            [3] => 2016-08-17 00:00:00
            [prod_date] => 2016-08-17 00:00:00
            [4] => report
            [type] => report
            [5] => 1
            [status] => 1
            [6] => Mohit Parmar
            [author_id] => Mohit Parmar
            [7] => 15.461596488952637
            [relevance] => 15.461596488952637
        )

    [8] => Array
        (
            [0] => 2016 Paroxetine Base (CAS 61869-08-7) Industry Market Report
            [title] => 2016 Paroxetine Base (CAS 61869-08-7) Industry Market Report
            [1] => 10281237
            [prod_id] => 10281237
            [2] => 18,20
            [cat_names] => 18,20
            [3] => 2016-08-17 00:00:00
            [prod_date] => 2016-08-17 00:00:00
            [4] => report
            [type] => report
            [5] => 1
            [status] => 1
            [6] => Mohit Parmar
            [author_id] => Mohit Parmar
            [7] => 15.461596488952637
            [relevance] => 15.461596488952637
        )

    [9] => Array
        (
            [0] => 2016 Paroxetine (CAS 61869-08-7) Industry Market Report
            [title] => 2016 Paroxetine (CAS 61869-08-7) Industry Market Report
            [1] => 10288051
            [prod_id] => 10288051
            [2] => 18,19
            [cat_names] => 18,19
            [3] => 2016-08-30 00:00:00
            [prod_date] => 2016-08-30 00:00:00
            [4] => report
            [type] => report
            [5] => 1
            [status] => 1
            [6] => Mohit Parmar
            [author_id] => Mohit Parmar
            [7] => 15.461596488952637
            [relevance] => 15.461596488952637
        )

)

United States Paroxetine Market Report 2017

Notes:
Sales, means the sales volume of Paroxetine
Revenue, means the sales value of Paroxetine

This report studies sales (consumption) of Paroxetine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
Teva
Emcure
Novartis
Mylan
Squibb
Sandoz
Hikma Pharmaceuticals
GSK
Mayne Pharma Inc
Bedford Laboratories
Abbott
Takeda
Sino-American Tianjin Smith Kline
Beijing Wansheng Pharmaceutical
Zhejiang Huahai Pharmaceutical
Zhejiang Jianfeng Pharmaceutical Holdings
GlaxoSmithKline
Sun Pharmaceutical Industries Limited

Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Paroxetine in each application, can be divided into
Application 1
Application 2

Table of Contents

United States Paroxetine Market Report 2017
1 Paroxetine Overview
1.1 Product Overview and Scope of Paroxetine
1.2 Classification of Paroxetine
1.2.1 Type I
1.2.2 Type II
1.3 Application of Paroxetine
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Paroxetine (2012-2022)
1.4.1 United States Paroxetine Sales and Growth Rate (2012-2022)
1.4.2 United States Paroxetine Revenue and Growth Rate (2012-2022)

2 United States Paroxetine Competition by Manufacturers
2.1 United States Paroxetine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Paroxetine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Paroxetine Average Price by Manufactures (2015 and 2016)
2.4 Paroxetine Market Competitive Situation and Trends
2.4.1 Paroxetine Market Concentration Rate
2.4.2 Paroxetine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion

3 United States Paroxetine Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Paroxetine Sales and Market Share by States (2012-2017)
3.2 United States Paroxetine Revenue and Market Share by States (2012-2017)
3.3 United States Paroxetine Price by States (2012-2017)

4 United States Paroxetine Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Paroxetine Sales and Market Share by Type (2012-2017)
4.2 United States Paroxetine Revenue and Market Share by Type (2012-2017)
4.3 United States Paroxetine Price by Type (2012-2017)
4.4 United States Paroxetine Sales Growth Rate by Type (2012-2017)

5 United States Paroxetine Sales (Volume) by Application (2012-2017)
5.1 United States Paroxetine Sales and Market Share by Application (2012-2017)
5.2 United States Paroxetine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Paroxetine Manufacturers Profiles/Analysis
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Paroxetine Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Teva
6.2.2 Paroxetine Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Teva Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Emcure
6.3.2 Paroxetine Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Emcure Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Novartis
6.4.2 Paroxetine Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Novartis Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Mylan
6.5.2 Paroxetine Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Mylan Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Squibb
6.6.2 Paroxetine Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Squibb Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Sandoz
6.7.2 Paroxetine Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Sandoz Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Hikma Pharmaceuticals
6.8.2 Paroxetine Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Hikma Pharmaceuticals Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 GSK
6.9.2 Paroxetine Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 GSK Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Mayne Pharma Inc
6.10.2 Paroxetine Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Mayne Pharma Inc Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Bedford Laboratories
6.12 Abbott
6.13 Takeda
6.14 Sino-American Tianjin Smith Kline
6.15 Beijing Wansheng Pharmaceutical
6.16 Zhejiang Huahai Pharmaceutical
6.17 Zhejiang Jianfeng Pharmaceutical Holdings
6.18 GlaxoSmithKline
6.19 Sun Pharmaceutical Industries Limited

7 Paroxetine Manufacturing Cost Analysis
7.1 Paroxetine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Paroxetine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Paroxetine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Paroxetine Major Manufacturers in 2015
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Paroxetine Market Forecast (2017-2022)
11.1 United States Paroxetine Sales, Revenue Forecast (2017-2022)
11.2 United States Paroxetine Sales Forecast by Type (2017-2022)
11.3 United States Paroxetine Sales Forecast by Application (2017-2022)
11.4 Paroxetine Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix
Methodology
Analyst Introduction
Data Source

List of Figures, Tables and Charts Available in United States Paroxetine Market Report 2017

List of Tables and Figures

Figure Picture of Paroxetine
Table Classification of Paroxetine
Figure United States Sales Market Share of Paroxetine by Type in 2015
Table Application of Paroxetine
Figure United States Sales Market Share of Paroxetine by Application in 2015
Figure United States Paroxetine Sales and Growth Rate (2012-2022)
Figure United States Paroxetine Revenue and Growth Rate (2012-2022)
Table United States Paroxetine Sales of Key Manufacturers (2015 and 2016)
Table United States Paroxetine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Paroxetine Sales Share by Manufacturers
Figure 2016 Paroxetine Sales Share by Manufacturers
Table United States Paroxetine Revenue by Manufacturers (2015 and 2016)
Table United States Paroxetine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Paroxetine Revenue Share by Manufacturers
Table 2016 United States Paroxetine Revenue Share by Manufacturers
Table United States Market Paroxetine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Paroxetine Average Price of Key Manufacturers in 2015
Figure Paroxetine Market Share of Top 3 Manufacturers
Figure Paroxetine Market Share of Top 5 Manufacturers
Table United States Paroxetine Sales by States (2012-2017)
Table United States Paroxetine Sales Share by States (2012-2017)
Figure United States Paroxetine Sales Market Share by States in 2015
Table United States Paroxetine Revenue and Market Share by States (2012-2017)
Table United States Paroxetine Revenue Share by States (2012-2017)
Figure Revenue Market Share of Paroxetine by States (2012-2017)
Table United States Paroxetine Price by States (2012-2017)
Table United States Paroxetine Sales by Type (2012-2017)
Table United States Paroxetine Sales Share by Type (2012-2017)
Figure United States Paroxetine Sales Market Share by Type in 2015
Table United States Paroxetine Revenue and Market Share by Type (2012-2017)
Table United States Paroxetine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Paroxetine by Type (2012-2017)
Table United States Paroxetine Price by Type (2012-2017)
Figure United States Paroxetine Sales Growth Rate by Type (2012-2017)
Table United States Paroxetine Sales by Application (2012-2017)
Table United States Paroxetine Sales Market Share by Application (2012-2017)
Figure United States Paroxetine Sales Market Share by Application in 2015
Table United States Paroxetine Sales Growth Rate by Application (2012-2017)
Figure United States Paroxetine Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Paroxetine Sales Market Share (2012-2017)
Table Teva Basic Information List
Table Teva Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Paroxetine Sales Market Share (2012-2017)
Table Emcure Basic Information List
Table Emcure Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Emcure Paroxetine Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Paroxetine Sales Market Share (2012-2017)
Table Mylan Basic Information List
Table Mylan Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mylan Paroxetine Sales Market Share (2012-2017)
Table Squibb Basic Information List
Table Squibb Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Squibb Paroxetine Sales Market Share (2012-2017)
Table Sandoz Basic Information List
Table Sandoz Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sandoz Paroxetine Sales Market Share (2012-2017)
Table Hikma Pharmaceuticals Basic Information List
Table Hikma Pharmaceuticals Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hikma Pharmaceuticals Paroxetine Sales Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
Table GSK Paroxetine Sales Market Share (2012-2017)
Table Mayne Pharma Inc Basic Information List
Table Mayne Pharma Inc Paroxetine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Mayne Pharma Inc Paroxetine Sales Market Share (2012-2017)
Table Bedford Laboratories Basic Information List
Table Abbott Basic Information List
Table Takeda Basic Information List
Table Sino-American Tianjin Smith Kline Basic Information List
Table Beijing Wansheng Pharmaceutical Basic Information List
Table Zhejiang Huahai Pharmaceutical Basic Information List
Table Zhejiang Jianfeng Pharmaceutical Holdings Basic Information List
Table GlaxoSmithKline Basic Information List
Table Sun Pharmaceutical Industries Limited Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Paroxetine
Figure Manufacturing Process Analysis of Paroxetine
Figure Paroxetine Industrial Chain Analysis
Table Raw Materials Sources of Paroxetine Major Manufacturers in 2015
Table Major Buyers of Paroxetine
Table Distributors/Traders List
Figure United States Paroxetine Production and Growth Rate Forecast (2017-2022)
Figure United States Paroxetine Revenue and Growth Rate Forecast (2017-2022)
Table United States Paroxetine Production Forecast by Type (2017-2022)
Table United States Paroxetine Consumption Forecast by Application (2017-2022)
Table United States Paroxetine Sales Forecast by States (2017-2022)
Table United States Paroxetine Sales Share Forecast by States (2017-2022)

Report Title

Published Date

Price

Global Paroxetine Market Research Report 2017\n
No. of Pages: 127

Notes: Production, means the output of Paroxetine Revenue, means the sales value of Paroxetine This report studies Paroxetine in Global market, especially in

26-Jan-2017
2900
Europe Paroxetine Market Report 2017
No. of Pages: 124

Notes: Sales, means the sales volume of Paroxetine Revenue, means the sales value of Paroxetine This report studies sales (consumption) of Paroxetine in

21-Feb-2017
3900
China Paroxetine Market Research Report 2017
No. of Pages: 119

Notes: Sales, means the sales volume of Paroxetine Revenue, means the sales value of Paroxetine This report studies Paroxetine in China market, focuses

28-Feb-2017
3200
Global Paroxetine Market Analysis & Forecast Report 2017-2022
No. of Pages: 104

The Global Paroxetine Market Analysis & Forecast Report 2017-2022 is a professional and in-depth study on the current state of

17-Feb-2017
2600
Global and Chinese Paroxetine HCl’ Hemihydrate (CAS 110429-35-1) Industry, 2016 Market Research Report
No. of Pages: 150

The 'Global and Chinese Paroxetine HCl’ Hemihydrate Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the

08-Jun-2016
2800
Global and Chinese Paroxetine hcl Industry, 2016 Market Research Report
No. of Pages: 150

The 'Global and Chinese Paroxetine hcl Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current

28-Jul-2016
2800